Biofermin Pharmaceutical
Biofermin Pharmaceutical Co., Ltd. is dedicated to providing pharmaceutical products and information, with a focus on medical and general medicines. The company emphasizes corporate responsibility, transparency, and innovation in healthcare. It has integrated its medical drug information with Taisho Pharmaceutical's site as of November 29, 2023, and offers a range of products, corporate information, recruitment details, and customer support through its website.
Industries
Nr. of Employees
large (251-1000)
Patents
Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation
US-11376287-B2
View DetailsAgent for preventing or treating fat-associated diseases and/or inflammation
US-11224622-B2
View DetailsAgent for preventing or treating small intestinal injury induced by specific NSAID and PPI
US-11219650-B2
View Details
Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation
US-11376287-B2
View DetailsAgent for preventing or treating fat-associated diseases and/or inflammation
US-11224622-B2
View DetailsAgent for preventing or treating small intestinal injury induced by specific NSAID and PPI
US-11219650-B2
View DetailsProducts
Over-the-counter probiotic oral medicines
Consumer-oriented probiotic oral tablet products distributed through retail and online marketplaces.
Prescription pharmaceutical products (information consolidated to partner site)
Prescription product information is maintained and provided via a partner medical product information site; indicates company involvement in prescription product manufacture or distribution.
Over-the-counter probiotic oral medicines
Consumer-oriented probiotic oral tablet products distributed through retail and online marketplaces.
Prescription pharmaceutical products (information consolidated to partner site)
Prescription product information is maintained and provided via a partner medical product information site; indicates company involvement in prescription product manufacture or distribution.
Services
Telephone-based customer support for product inquiries with recorded calls to ensure accuracy.
Publication of notices and PDF communications regarding product supply status, packaging changes, and distribution controls.
Telephone-based customer support for product inquiries with recorded calls to ensure accuracy.
Publication of notices and PDF communications regarding product supply status, packaging changes, and distribution controls.
Expertise Areas
- Pharmaceutical manufacturing (API through finished dosage)
- Quality assurance and regulatory compliance
- Quality control and analytical testing
- Supply chain and production management
Key Technologies
- API synthesis and handling
- Formulation development for oral dosage forms
- Pharmaceutical packaging workflows
- Quality control testing (analytical and microbiological) (inferred)
News & Updates
Announcement regarding the suspension of some packaging sales of products as of April 21, 2025.
Details about the company's efforts to ensure the stable supply of medical pharmaceuticals as of April 15, 2025.
Notice about the lifting of restrictions on shipments of medical drugs due to increased demand as of April 1, 2025.
Announcement regarding the suspension of some packaging sales of products as of April 21, 2025.
Details about the company's efforts to ensure the stable supply of medical pharmaceuticals as of April 15, 2025.
Notice about the lifting of restrictions on shipments of medical drugs due to increased demand as of April 1, 2025.